Evidence map›Paper›PMID 39367102›Full record

ArticleScientific reports2024

Impact of photobiomodulation therapy on pro-inflammation functionality of human peripheral blood mononuclear cells - a preliminary study.

Kamila Pasternak-Mnich, Jolanta Kujawa, Justyna Agier, Elżbieta Kozłowska

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kamila Pasternak-MnichDepartment of Medical Rehabilitation, Faculty of Health Sciences, Medical University of Lodz, 251 Pomorska St, Lodz, 92-213, Poland. kamila.pasternak@umed.lodz.pl.ORCID 0000-0002-3819-5478
Jolanta KujawaDepartment of Medical Rehabilitation, Faculty of Health Sciences, Medical University of Lodz, 251 Pomorska St, Lodz, 92-213, Poland.ORCID 0000-0003-1309-2728
Justyna AgierDepartment of Microbiology, Genetics and Experimental Immunology, Lodz Centre of Molecular Studies on Civilisation Diseases, Medical University of Lodz, Lodz, 92-215, Poland.ORCID 0000-0002-6759-5737
Elżbieta KozłowskaDepartment of Microbiology, Genetics and Experimental Immunology, Lodz Centre of Molecular Studies on Civilisation Diseases, Medical University of Lodz, Lodz, 92-215, Poland.ORCID 0000-0003-2867-9126

Funding

National Science Centre, Poland 2022/06/X/NZ7/00241
6 · The paper itself

Abstract

Research into the efficacy of photobiomodulation therapy (PBMT) in reducing inflammation has been ongoing for years, but standards for irradiation methodology still need to be developed. This study aimed to test whether PBMT stimulates in vitro human peripheral blood mononuclear cells (PBMCs) to synthesize pro-inflammatory cytokines, including chemokines. PBMCs were irradiated with laser radiation at two wavelengths simultaneously (λ = 808 nm in continuous emission and λ = 905 nm in pulsed emission). The laser radiation energy was dosed in one dose as a whole (5 J, 15 J, 20 J) or in a fractionated way (5 J + 15 J and 15 J + 5 J) with a frequency of 500, 1,500 and 2,000 Hz. The surface power densities were 177, 214 and 230 mW/cm

Indexed as

InflammationLeukocytes, MononuclearLow-Level Light TherapyCells, CulturedChemokine CCL2ChemokinesCytokinesHumansInterleukin-1betaChemokine CCL2ChemokinesCytokinesInterleukin-1betaCytokinesInflammationLow-level laser therapy (LLLT)MLS M1 systemPeripheral blood mononuclear cells (PBMCs)Photobiomodulation Therapy (PBMT)

Identifiers

PMID39367102
PMCPMC11452683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.